Disparities in availability of new cancer drugs worldwide: 1990-2022.

Introduction: Despite progress in the development of new cancer drugs, concerns about equity of access remain. This study aimed to examine the availability and timeliness of availability of new cancer drugs around the globe over the past three decades and their associations with country characteristics.

Methods: From a pharmaceutical intelligence database we identified new cancer drugs launched between 1990 and 2022.